免疫指标在结核性胸腔积液诊断中的研究进展
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:


Advances in immune markers research for tuberculous pleural effusion diagnosis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    结核性胸腔积液是结核病高发地区常见的胸腔积液病因,特定生物标志物检测有助于对结核性胸腔积液的快速诊断。结核病的病理生理学在很大程度上是一种免疫反应,与大量的细胞因子和趋化因子密切相关。在胸腔积液中寻找能够指示结核性胸腔积液(TPE)进程和免疫状态的分子标志物是近年研究的热点,其中重点以干扰素γ、白细胞介素家族等细胞因子为代表。一些学者也提出了新的具有前景的诊断方法,但需要更多的基础研究和临床研究进行验证。本文就用于结核性胸腔积液诊断方面的免疫标志物、新的诊断方法进展做一综述,以供临床实践及未来诊断新技术的开发参考与借鉴

    Abstract:

    Tuberculous pleural effusion is a common cause of pleural effusion in areas with high incidence of tuberculosis. The detection of specific biomarkers is helpful for the rapid diagnosis of tuberculous pleural effusion. The pathophysiology of tuberculosis is to a large extent an immune response, which is closely related to a large number of cytokines and chemokines. Searching for molecular markers that can indicate TPE progression and immune status in pleural effusion is a hot topic in recent years, which is represented by cytokines such as interferon-γ and interleukin family. Some scholars have also proposed new promising diagnostic methods, but more basic research and clinical research are needed to verify them. This article reviews the progress of immune markers and new diagnostic methods in the diagnosis of tuberculous pleural effusion, which can be used as a reference for clinical practice and the development of new diagnostic techniques in the future

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-01-19
您是第位访问者
网站版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403 本网站支持 IPv6    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司